MDQK.HM stock jumped 200.00% intraday on HAM in Germany to €7.50 on 25 Mar 2026. The move followed a low opening at €2.50 and triggered a high of €7.50 on light but notable volume of 35.00 shares versus an average of 41.00. This rapid swing put MediNavi AG in the high-volume movers list for market hours and forced short-term traders to reassess risk. We use Meyka AI as an AI-powered market analysis platform to map where momentum meets fundamentals for MediNavi AG (MDQK.HM) on HAM
MDQK.HM stock intraday move and volume drivers
The main fact is the intraday 200.00% gain to €7.50 from a €2.50 open. Volume reached 35.00 versus an average of 41.00, so this was a low-liquidity spike rather than broad institutional rush. The gap between the 50-day average (€2.50) and current price suggests traders reacted to a news or technical trigger rather than to updated fundamentals
Price and technical snapshot for MDQK.HM stock
Price range today was €2.50–€7.50, with year low €1.50 and year high €7.50. Short-term averages sit at €2.50 (50-day) and €2.00 (200-day). ATR is 5.00, showing extreme intraday volatility. Momentum indicators are not reliable given missing continuous data, so traders should treat today’s move as a high-volatility event with quick mean reversion risk
Fundamentals and valuation for MediNavi AG (MDQK.HM)
MediNavi AG lists in Healthcare and operates a doctor-finder and second-opinion platform. Public filings show weak operating metrics and limited reported revenue per share. Key ratios include an enterprise value over EBITDA of 2.17 and a current ratio of 41.50, reflecting a balance-sheet quirk rather than strong cash flow. There is no reported EPS or P/E, so valuation is effectively undefined and remains speculative
Meyka AI rates MDQK.HM with a score out of 100
Meyka AI rates MDQK.HM with a score of 62.43 / 100 and assigns a B grade with a HOLD suggestion. This grade factors in S&P 500 and sector comparisons, industry metrics, financial growth, forecasts, analyst consensus, and key ratios. The rating signals caution: momentum is present, but fundamentals and liquidity limit conviction
Meyka AI forecast and price outlook for MDQK.HM stock
Meyka AI’s forecast model projects a 12-month fair value near €3.20 versus the current €7.50, implying a downside of -57.33% from today. Short-term scenarios include a bull momentum target of €10.00 (+33.33%) and a base-case retracement to the €2.50–€3.50 range. Forecasts are model-based projections and not guarantees
Risks, catalysts and sector context for MDQK.HM stock
Key risks are low liquidity, sparse reporting, and absent EPS data. Catalysts that could sustain higher pricing include a clear corporate update, new revenue contracts, or listing-related news. Healthcare sector trends are soft YTD, with the sector down around -4.09% year to date, so MDQK.HM will need company-specific news to diverge from peers
Final Thoughts
MDQK.HM stock recorded a dramatic intraday spike to €7.50 on 25 Mar 2026, with volume of 35.00 shares that still leaves liquidity thin. That combination creates sharp trading opportunities and meaningful downside risk. Meyka AI assigns MDQK.HM a 62.43 score (Grade B, HOLD) and models a 12-month fair value near €3.20, implying -57.33% from the current price. Traders should treat today as a high-volume mover event rather than a durable revaluation. Short-term traders can play momentum with tight stops. Longer-term investors need clearer revenue, EPS disclosure, or a sustained rise above €10.00 to warrant repositioning. All forecasts are model-based projections and not guarantees, and investors should confirm company disclosures before acting. For company detail visit MediNavi’s site source and the symbol image source
FAQs
Why did MDQK.HM stock jump 200.00% today?
The spike to €7.50 was driven by low liquidity and a price gap from €2.50. No confirmed earnings or SEC-style announcement explains the move. Low average volume means small orders can create large percentage swings.
What is Meyka AI’s outlook for MDQK.HM stock?
Meyka AI’s model projects a 12-month fair value of €3.20, implying -57.33% versus €7.50. The model flags limited fundamentals and advises caution; forecasts are projections, not guarantees.
Should I trade MDQK.HM stock after the spike?
For active traders, short-term momentum trades are possible but require tight stops because ATR is 5.00 and liquidity is low. Long-term investors should wait for clear revenue and EPS disclosures.
How does MediNavi AG compare to the Healthcare sector?
MDQK.HM lacks P/E and EPS data, while the Healthcare sector average P/E sits near 28.86. Without reliable financials, MediNavi cannot be easily compared to sector peers.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)